Drugs / IPX054
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00279825 | Jan 2006 → Dec 2007 | Parkinson disease | Impax Laboratories, LLC | Completed | No outcome recorded |
News releases announcing trial results or a regulatory action · 1
| Date | Issuer | Release |
|---|---|---|
| 2007-06-08 | Impax Laboratories, LLC | Results IMPAX Presents at Movement Disorder Society's 11th International Congress of Parkinson's Disease and Movement Disorders amneal.com ↗
The combined immediate- and extended-release preparation may offer benefits in treating Parkinson's Disease (PD) patients with motor fluctuations. |
All press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2007-06-08 | Impax Laboratories, LLC | IMPAX Presents at Movement Disorder Society's 11th International Congress of Parkinson's Disease and Movement Disorders amneal.com ↗ |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IPX054 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00279825 ↗ |